Legal Opinion
In Re Wellbutrin SR/Zyban Antitrust Litigation
District Court, E.D. Pennsylvania
Decided July 24, 2003No. 2:02-cv-04398PublishedCited by 19 opinions
1Opinion of the Court
MEMORANDUM AND ORDER
KAUFFMAN, District Judge.
Plaintiffs bring this putative class action on behalf of all indirect purchasers of Wellbutrin SR and Zyban (‘Wellbutrin SR”) 1 alleging that Defendants GlaxoS-mithKline pic and SmithKline Beecham Corporation (“Defendants”) engaged in a series of anticompetitive and unlawful actions that extended their exclusivity of the sale of Wellbutrin SR. Plaintiffs assert that they are entitled to injunctive relief under Section 16 of the Clayton Act as a result of Defendants’ monopolization and attempted monopolization in violation of Section 2 of the…
2Cases cited11 opinions
- Pension Benefit Guaranty Corporation v. White Consolidated Industries, Inc., C/o Ct Corporation Systems Registered AgentCourt of Appeals for the Third Circuit · 1993
- H. J. Inc. v. Northwestern Bell Telephone Co.Supreme Court of the United States · 1989
- United States v. Grinnell Corp.Supreme Court of the United States · 1966
- Zenith Radio Corp. v. Hazeltine Research, Inc.Supreme Court of the United States · 1969
- Atlantic Richfield Co. v. USA Petroleum Co.Supreme Court of the United States · 1990
6 more not listed; retrieve them via the Exa API.
3Cited by19 opinions
- United States ex rel. Spay v. CVS Caremark Corp.District Court, E.D. Pennsylvania · 2012
- Clements v. Sanofi-Aventis, U.S., Inc.District Court, D. New Jersey · 2015
- Simpson v. FerryDistrict Court, E.D. Pennsylvania · 2016
- In re Egalet Corp.District Court, E.D. Pennsylvania · 2018
- In Re Gabapentin Patent LitigationDistrict Court, D. New Jersey · 2009
14 more not listed; retrieve them via the Exa API.